On the HCPLive Atopic Dermatitis condition center page, resources on the topics of medical news and expert insight into eczema can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dermatitis research, treatment, and drug development.
April 30th 2024
The decision by Eli Lilly to resubmit lebrikizumab to the FDA for adults and adolescents with eczema is expected to receive a response in the second half of the year.
Study Finds No Significant Link Between Atopic Dermatitis Severity Scores, Peanut Sensitivity
Research suggested no significant relationship between peanut sensitivity and AD severity as measured by two scores, although the study was acknowledged to have a smaller population due to pandemic restrictions.
Markus Boos, MD, PhD: Atopic Dermatitis Connections to Climate Change, Environmental Factors
A discussion with the moderator of the Global Parents for Eczema Research symposium regarding climate change and the effects of fire, drought, airborne pollution on atopic dermatitis.
Alopecia Areata, Atopic Dermatitis Successfully Treated by Switching to Baricitinib
A recent research letter highlighted a case observed in Japan in which a patient with alopecia totalis, and an associated case of atopic dermatitis, was treated effectively with baricitinib, a JAK inhibitor.